Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03794856 · ClinicalTrials.gov registry record
The Dallas Asthma Brain and Cognition (ABC) Study
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 130
- Enrollment target
NCT03794856: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT03794856 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 130 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03794856 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
Study Summary
Asthma is a chronic inflammatory airway disease that leads to episodic symptom exacerbations, which exerts a substantial burden on quality of life and can influence other health domains if not adequately controlled. Asthma prevalence rates have increased in the past decade, affecting 8.4% (25.7 million people) of the United States population. The economic costs of asthma have been estimated annually with $56 billion in the US alone. Despite progress in pharmacological treatment, overall asthma control remains unsatisfactory and treatment non-adherence is extremely high. Asthma is particularly under diagnosed and understudied in aging adults. This problem will increase in coming decades given demographic trends and will disproportionally contribute to the societal and personal economic costs associated with asthma treatment and management. In the proposed 4-year project we will evaluate, in a two-session assessment recruiting a total of 126 asthma patients and 66 healthy controls aged 40-69 years, the extent to which asthma and aging are associated with changes in cognition and brain chemistry, structure, and function.
Primary Outcome
The Wechsler Adult Intelligence Scale (WAIS) Symbol Search test is a subtest of the WAIS, a scale widely used to measure intelligence. The examinee scans a search group of symbols and indicates whether one of the symbols matches a symbol in the target group. The time limit for this subtest is 120 seconds. The total raw score is the sum of the number of correct responses minus the number of incorrect responses. A higher score indicates better performance. The maximum total raw score is 60. If the
Interventions
- OTHER Functional and Structural Magnetic Resonance Imaging (research grade)
- OTHER Cognitive Function Testing (non-diagnostic)
- OTHER Asthma and Psychological Questionnaires (non-diagnostic)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2019-02-21 |
| Est. Completion | 2025-05-28 |
What the finished NCT03794856 record still lists
NCT03794856 is an observational study that tracks outcomes without assigning an intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Functional and Structural Magnetic Resonance Imaging (research grade) is the first listed.
NCT03794856 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03794856 about?
NCT03794856 is a clinical study titled "The Dallas Asthma Brain and Cognition (ABC) Study". Asthma is a chronic inflammatory airway disease that leads to episodic symptom exacerbations, which exerts a substantial burden on quality of life and can influence other health domains if not adequately controlled. Asthma prevalence rates have increased in the past decade, affecting 8.4% (25.7 mill...
What is the current status of trial NCT03794856?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2019-02-21. Estimated completion is 2025-05-28.
What interventions are being tested in trial NCT03794856?
The interventions under investigation include: Functional and Structural Magnetic Resonance Imaging (research grade) (OTHER), Cognitive Function Testing (non-diagnostic) (OTHER), Asthma and Psychological Questionnaires (non-diagnostic) (OTHER).
Who is sponsoring clinical trial NCT03794856?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI